Suppr超能文献

对麻醉药物过敏的持续性。

Persistence of allergy to anaesthetic drugs.

作者信息

Fisher M M, Baldo B A

机构信息

Intensive Therapy Unit, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.

出版信息

Anaesth Intensive Care. 1992 May;20(2):143-6. doi: 10.1177/0310057X9202000203.

Abstract

Intradermal testing and RIA testing for specific IgE antibodies to neuromuscular blocking drugs (NMBDs) were performed in patients referred to an Anaesthetic Allergy Clinic. Six patients were initially investigated four to 29 years after clinical anaphylaxis during anaesthesia and two of these patients and sixteen others were investigated by intradermal testing on two occasions at least four years apart. Seven patients had RIA tests for NMBD-specific IgE antibodies on two occasions at the time of skin testing. In all but two patients the evidence for drug-specific antibodies persisted 4-29 years after the reactions. In one patient all tests became negative and in another the skin test became negative but the positive RIA persisted. Evidence of antibodies to NMBDs persisted in 21 of 22 patients who had had anaphylactic reactions to these drugs during anaesthesia. In the absence of evidence of allergy diminishing with time in the majority of patients it would seem wise to avoid drugs responsible for reactions for the rest of the patient's life.

摘要

对转诊至麻醉过敏诊所的患者进行了针对神经肌肉阻滞药物(NMBDs)特异性IgE抗体的皮内试验和放射免疫分析(RIA)检测。6例患者在麻醉期间发生临床过敏反应后的4至29年进行了初步调查,其中2例患者以及另外16例患者接受了至少间隔4年的两次皮内试验。7例患者在皮肤试验时进行了两次针对NMBD特异性IgE抗体的RIA检测。除2例患者外,所有患者体内药物特异性抗体的证据在反应发生后的4至29年持续存在。1例患者所有检测结果均变为阴性,另1例患者皮内试验结果变为阴性,但RIA检测仍为阳性。在22例麻醉期间对这些药物发生过敏反应的患者中,21例患者体内存在针对NMBDs的抗体证据。由于大多数患者并未出现过敏证据随时间减少的情况,因此在患者余生中避免使用引发反应的药物似乎是明智的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验